All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B Virus Infection-28325923

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	28325923	A184V			Hepatitis B Virus Infection	R L	View
2	28325923	L173P	S	S	Hepatitis B Virus Infection	R I L	View
3	28325923	Q181R	S	S	Hepatitis B Virus Infection	R I L	View
4	28325923	C332S	RT	P	Hepatitis B Virus Infection	R L	View
5	28325923	C69P	X	X	Hepatitis B Virus Infection	R L	View
6	28325923	K160R	S	S	Hepatitis B Virus Infection	R I L	View
7	28325923	L336M	RT	P	Hepatitis B Virus Infection	R L	View
8	28325923	L55F	X	X	Hepatitis B Virus Infection	R L	View
9	28325923	L58P	X	X	Hepatitis B Virus Infection	R L	View
10	28325923	R153Q	RT	P	Hepatitis B Virus Infection	R L	View
11	28325923	R56P	X	X	Hepatitis B Virus Infection	R L	View
12	28325923	S256G	RT	P	Hepatitis B Virus Infection	R L	View
13	28325923	S54P	X	X	Hepatitis B Virus Infection	R L	View
14	28325923	Y221C	S	S	Hepatitis B Virus Infection	D R L	View
15	28325923	G145R	S	S	Hepatitis B Virus Infection	G R I L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.